OTCMKTS:CHBT - China-Biotics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email China-Biotics, Inc. is engaged in the research, development, production, marketing, and distribution of probiotics products, which contains live microbial food supplements. It operates in two segments: retail products and bulk additive products. The Company's retail products include Shining Essence, Shining Sicanel Capsules and Probiotics Protein Powder. It manufactures and sells three categories of bulk additive products, which includes Yoghurt Culture Starter, Probotic Powder and Strains. The Company focuses on two industries in China, such as the dairy and animal feed sectors. The Company's Shining Essence composed of lactobacillus acidophilus and bifidobacterium bifidum, aimed at balancing the microecology of the human digestive system, enhancing intestinal health, and protecting and strengthening liver function. Shining Sicanel Capsules composed of lactobacillus acidophilus, focused on reducing hyperlipidemia, or excess fat in the blood. Receive CHBT News and Ratings via Email Sign-up to receive the latest news and ratings for CHBT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:CHBT Previous Symbol CUSIPN/A WebN/A Phone+86-21-58349748Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A OptionableNot Optionable China-Biotics (OTCMKTS:CHBT) Frequently Asked Questions What is China-Biotics' stock symbol? China-Biotics trades on the OTCMKTS under the ticker symbol "CHBT." Has China-Biotics been receiving favorable news coverage? News headlines about CHBT stock have been trending somewhat negative on Thursday, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. China-Biotics earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. How do I buy shares of China-Biotics? Shares of CHBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How can I contact China-Biotics? China-Biotics' mailing address is Jinqiao Export Pro No.999 Ningqiao Road, Pudong District, SHANGHAI, SHA 201206, China. The company can be reached via phone at +86-21-58349748. MarketBeat Community Rating for China-Biotics (OTCMKTS CHBT)Community Ranking: 1.6 out of 5 ()Outperform Votes: 22 (Vote Outperform)Underperform Votes: 46 (Vote Underperform)Total Votes: 68MarketBeat's community ratings are surveys of what our community members think about China-Biotics and other stocks. Vote "Outperform" if you believe CHBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHBT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?